rs151220873

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_006432.5(NPC2):​c.88G>A​(p.Val30Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00139 in 1,588,322 control chromosomes in the GnomAD database, including 15 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0014 ( 15 hom. )

Consequence

NPC2
NM_006432.5 missense

Scores

3
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts P:1B:15

Conservation

PhyloP100: -1.97

Publications

19 publications found
Variant links:
Genes affected
NPC2 (HGNC:14537): (NPC intracellular cholesterol transporter 2) This gene encodes a protein containing a lipid recognition domain. The encoded protein may function in regulating the transport of cholesterol through the late endosomal/lysosomal system. Mutations in this gene have been associated with Niemann-Pick disease, type C2 and frontal lobe atrophy. [provided by RefSeq, Jul 2008]
NPC2 Gene-Disease associations (from GenCC):
  • Niemann-Pick disease, type C2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Myriad Women’s Health, G2P, Genomics England PanelApp, Laboratory for Molecular Medicine, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Niemann-Pick disease type C, adult neurologic onset
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Niemann-Pick disease type C, juvenile neurologic onset
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Niemann-Pick disease type C, late infantile neurologic onset
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Niemann-Pick disease type C, severe early infantile neurologic onset
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Niemann-Pick disease type C, severe perinatal form
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0055167973).
BP6
Variant 14-74486431-C-T is Benign according to our data. Variant chr14-74486431-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 183281.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00133 (203/152276) while in subpopulation SAS AF = 0.00497 (24/4826). AF 95% confidence interval is 0.00343. There are 0 homozygotes in GnomAd4. There are 100 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 15 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NPC2NM_006432.5 linkc.88G>A p.Val30Met missense_variant Exon 2 of 5 ENST00000555619.6 NP_006423.1
NPC2NM_001363688.1 linkc.88G>A p.Val30Met missense_variant Exon 2 of 4 NP_001350617.1
NPC2NM_001375440.1 linkc.88G>A p.Val30Met missense_variant Exon 2 of 4 NP_001362369.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NPC2ENST00000555619.6 linkc.88G>A p.Val30Met missense_variant Exon 2 of 5 1 NM_006432.5 ENSP00000451112.2 P61916-1

Frequencies

GnomAD3 genomes
AF:
0.00135
AC:
205
AN:
152158
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000265
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000851
Gnomad ASJ
AF:
0.0193
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00538
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00118
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.00213
AC:
442
AN:
207464
AF XY:
0.00247
show subpopulations
Gnomad AFR exome
AF:
0.0000758
Gnomad AMR exome
AF:
0.000918
Gnomad ASJ exome
AF:
0.0194
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00106
Gnomad OTH exome
AF:
0.00454
GnomAD4 exome
AF:
0.00139
AC:
1999
AN:
1436046
Hom.:
15
Cov.:
31
AF XY:
0.00158
AC XY:
1126
AN XY:
711534
show subpopulations
African (AFR)
AF:
0.000481
AC:
16
AN:
33266
American (AMR)
AF:
0.000984
AC:
40
AN:
40658
Ashkenazi Jewish (ASJ)
AF:
0.0189
AC:
482
AN:
25500
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39216
South Asian (SAS)
AF:
0.00495
AC:
407
AN:
82274
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51960
Middle Eastern (MID)
AF:
0.0124
AC:
71
AN:
5738
European-Non Finnish (NFE)
AF:
0.000737
AC:
809
AN:
1097992
Other (OTH)
AF:
0.00293
AC:
174
AN:
59442
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.455
Heterozygous variant carriers
0
111
222
333
444
555
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00133
AC:
203
AN:
152276
Hom.:
0
Cov.:
32
AF XY:
0.00134
AC XY:
100
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.000265
AC:
11
AN:
41554
American (AMR)
AF:
0.000850
AC:
13
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.0193
AC:
67
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5190
South Asian (SAS)
AF:
0.00497
AC:
24
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10600
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.00118
AC:
80
AN:
68026
Other (OTH)
AF:
0.00142
AC:
3
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
10
20
30
40
50
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00188
Hom.:
4
Bravo
AF:
0.00134
TwinsUK
AF:
0.00108
AC:
4
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00291
AC:
25
ExAC
AF:
0.00156
AC:
189
Asia WGS
AF:
0.00202
AC:
7
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Pathogenic:1Benign:15
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:8
May 28, 2019
Mendelics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 19, 2017
Mayo Clinic Laboratories, Mayo Clinic
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

NPC2: BP4, BS1, BS2 -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Oct 06, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 32858489, 15465422, 30556376, 15937921, 12955717, 25764212, 24386122, 21228398, 27792009, 25558065, 27884173, 25099932) -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Niemann-Pick disease, type C2 Benign:5
May 18, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 18, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 21, 2022
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 17, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
Jul 06, 2022
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: NPC2 c.88G>A (p.Val30Met) results in a conservative amino acid change located in the MD-2-related lipid-recognition domain (IPR003172) of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0021 in 207464 control chromosomes, predominantly at a frequency of 0.0046 within the South Asian subpopulation in the gnomAD database, including 3 homozygotes. The observed variant frequency within South Asian control individuals in the gnomAD database is approximately 7-fold of the estimated maximal expected allele frequency for a pathogenic variant in NPC2 causing Niemann-Pick Disease Type C phenotype (0.00068), strongly suggesting that the variant is a benign polymorphism found primarily in populations of South Asian origin. To our knowledge, no penetrant association of c.88G>A with Niemann-Pick Disease Type C has been reported in the literature. A functional study examining the expression and localization of NPC2 missense variants in human fibroblasts found no biological abnormalities in cells expressing this variant, suggesting it does not strongly impact protein function (Chikh_2005). Seven assessments for this variant have been submitted to ClinVar after 2014 without evidence for independent evaluation and all classified the variant as benign (n=4) or likely benign (n=3). Based on the evidence outlined above, the variant was classified as benign. -

Aug 25, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Seizure;C0557874:Global developmental delay;C4551563:Microcephaly;C4551584:Brain atrophy Pathogenic:1
Dec 01, 2014
Genomic Medicine Center of Excellence, King Faisal Specialist Hospital and Research Centre
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:research

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.18
CADD
Benign
12
DANN
Uncertain
0.99
DEOGEN2
Benign
0.16
T;.;T;.;.;.;T
Eigen
Benign
-0.98
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.028
N
LIST_S2
Benign
0.77
T;T;T;T;T;T;T
M_CAP
Uncertain
0.11
D
MetaRNN
Benign
0.0055
T;T;T;T;T;T;T
MetaSVM
Benign
-0.53
T
MutationAssessor
Benign
1.3
.;L;L;.;.;.;.
PhyloP100
-2.0
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-0.34
N;N;N;N;N;N;N
REVEL
Uncertain
0.49
Sift
Benign
0.11
T;T;T;T;T;T;T
Sift4G
Benign
0.11
T;T;T;T;.;T;.
Polyphen
0.92
.;.;P;.;.;.;.
Vest4
0.69
MVP
0.42
MPC
1.1
ClinPred
0.060
T
GERP RS
-7.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.15
gMVP
0.41
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs151220873; hg19: chr14-74953134; COSMIC: COSV99467354; COSMIC: COSV99467354; API